Back to Search
Start Over
Design of Y 2 Receptor Selective and Proteolytically Stable PYY 3-36 Analogues.
- Source :
-
Journal of medicinal chemistry [J Med Chem] 2018 Dec 13; Vol. 61 (23), pp. 10519-10530. Date of Electronic Publication: 2018 Nov 20. - Publication Year :
- 2018
-
Abstract
- In recent years peptide YY (PYY) has attracted attention within the area of diabetes and obesity due to its involvement in food intake regulation and glucose homeostasis. It is well-known that PYY <subscript>1-36</subscript> is rapidly cleaved by dipeptidyl peptidase-4 to the more Y <subscript>2</subscript> receptor selective analogue PYY <subscript>3-36</subscript> , which is further cleaved to the inactive analogue PYY <subscript>3-34</subscript> . In order to improve the selectivity and proteolytic stability of the C-terminus, we synthesized several analogues incorporating N-methyl amino acids or β-homo amino acids and other non-natural amino acids. These were tested against all four NPY receptors, and highly potent and Y <subscript>2</subscript> receptor selective analogues were identified by combining a tryptophan residue in position 30 with either N-methyl or β-homo arginine in position 35. We also identified an analogue with a MeGln <superscript>34</superscript> substitution that surprisingly displayed high affinity toward all four receptors. In addition, these analogues displayed improved stability toward C-terminal proteolysis compared to native PYY <subscript>3-36</subscript> .
Details
- Language :
- English
- ISSN :
- 1520-4804
- Volume :
- 61
- Issue :
- 23
- Database :
- MEDLINE
- Journal :
- Journal of medicinal chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 30399314
- Full Text :
- https://doi.org/10.1021/acs.jmedchem.8b01046